Evidence map›Paper›PMID 41855233›Full record

ArticlePloS one2026

Robust 3D Pose estimation and Parkinson's Disease classification via Dual-Stage Adaptive Temporal Perception and graph topology modeling network.

Min Zuo, Jialu Li, Mingchao Chang, Qingchuan Zhang, Shibo Fan

Abstract read
In one paragraph

Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Min ZuoNational Engineering Research Center for Agriproduct Quality Traceability, Beijing Technology and Business University, Beijing, China.
Jialu LiNational Engineering Research Center for Agriproduct Quality Traceability, Beijing Technology and Business University, Beijing, China.
Mingchao ChangNational Engineering Research Center for Agriproduct Quality Traceability, Beijing Technology and Business University, Beijing, China.
Qingchuan ZhangNational Engineering Research Center for Agriproduct Quality Traceability, Beijing Technology and Business University, Beijing, China.ORCID https://orcid.org/0000-0003-4416-6750
Shibo FanSchool of Automation, Wuxi University, Wuxi, Jiangsu, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This paper proposes a unified skeleton-based framework for 3D human pose estimation and Parkinson's disease classification, integrating a Dual-Stage Adaptive Temporal Perception (DATP) strategy and an Adaptive Graph Topology Modeling Network (AGTM-Net). DATP enhances robustness to joint occlusion and sequence degradation through occlusion-aware interpolation, trend-extrapolated frame padding, and multi-scale spatiotemporal modeling. On the MPI-INF-3DHP dataset with 16 missing joints, DATP achieves 77.72 PCK and 43.57 AUC, outperforming state-of-the-art methods. On Human3.6M, DATP also shows strong generalization with MPJPE reduced to 32.68 mm. For clinical classification, AGTM-Net dynamically models skeletal structure variations and achieves an F1-score of 0.898 and accuracy of 0.881 in distinguishing healthy individuals from Parkinson's patients with a score of 0 based on the "3.9 Arising from Chair" task. Interpretability analyses-based on gradient and perturbation methods-highlight the spine, chest, and hips as decisive joints, aligning with clinical understanding of gait disorders and enhancing the model's transparency and clinical reliability.

Indexed as

Imaging, Three-DimensionalParkinson DiseasePostureTime PerceptionAlgorithmsGraph Neural NetworksHumansMale

Identifiers

PMID41855233
PMCPMC13001963

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.